Clinical Trials in Atlanta

Showing 3301-3320 of 9,468 trials

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

NCT04662151

The purpose of this study is to determine if an investigational drug, AT-100, can reduce the occurrence of Bronchopulmonary Dysplasia (BPD) in babies born premature, as compared to babies born premature who receive an air-sham alone.

Bronchopulmonary Dysplasia

Airway Therapeutics, Inc.37 participantsStarted Sep 2021

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +16 more locations

TERMINATEDPhase 2< 1 mile

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

NCT04352205

This phase II trial studies how well daratumumab-based therapy works in treating patients with newly diagnosed multiple myeloma with kidney failure. Daratumumab-based therapy includes daratumumab, bortezomib, dexamethasone, and thalidomide or lenalidomide. Daratumumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Bortezomib is a drug that prevents myeloma cells from getting rid of their waste products, leading to being targeted for death. Dexamethasone is a steroid that is commonly used, either alone or in combination with other drugs, to treat multiple myeloma. Lenalidomide and thalidomide may stop the growth of multiple myeloma by blocking the growth of new blood vessels necessary for tumor growth. Giving daratumumab, bortezomib, dexamethasone, and thalidomide or lenalidomide may be a good way to treat patients with newly diagnosed multiple myeloma with kidney failure.

Plasma Cell MyelomaRenal Failure

Emory University17 participantsStarted May 2020

Atlanta, Georgia, United States

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

Find Trials by Condition in Atlanta

Teaching Loved Ones to Help Veterans Optimize Their PTSD Care and Healing

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Measuring Cardiovascular Performance and Blood Flow Using Common But Never Compared Methods.

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

Efficacy of Human Placental Graft in Diabetic Foot Ulcers

R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma

Suicide Treatment Alternatives for Teens

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer